首页> 外文期刊>Pharmacoepidemiology and drug safety >Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia.
【24h】

Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia.

机译:埃塞俄比亚南部和中部的选定医院的高度活跃的抗逆转录病毒治疗遵守及其决定因素。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To determine the adherence rate and its determinants among people living with HIV/AIDS on highly active antiretroviral therapy (HAART) in selected governmental hospitals from central and south Ethiopia. METHODOLOGY: A cross-sectional study involving both qualitative and quantitative methods was conducted between August and October 2007 in Yirgalem, Hawassa, and Shashemene Hospitals. Quantitative data collection techniques include patient self-report and unannounced pill count and the qualitative methods employed were focus group discussions (FGDs), semi-structured interviews, and observations of health facilities. RESULTS: Whereas females accounted for 56.4% (238), male participants were 43.6% (184) of the total participants. Adherence rate was 93.1% using 15-days self-report, but the rate came down to 88.1% when calculated using the unannounced pill count method (n = 90). Multivariate analysis revealed that being unmarried (OR = 0.119, CI = 0.016-0.901, p = 0.039), unemployment (OR = 0.011, CI = 0.000-0.288, p = 0.007); failure to disclose HIV status (OR = 0.433, CI = 0.198-0.949, p = 0.037); lack of support from family (OR = 0.393, CI = 0.163-0.947, p = 0.037); or others (OR = 0.332, CI = 0.144-0.845, p = 0.043); alcohol drinking (OR = 0.210, CI = 0.071-0.617, p = 0.003); treatment regimen, stavudine(40)-lamuvidine-nevirapine (OR = 0.174, CI = 0.033-0.923, p = 0.040), azathymidine-lamuvidine-nevirapine (OR = 0.172, CI = 0.034-0.867, p = 0.033) and dosing three times daily (OR = 0.073, CI = 0.018-0.290, p = 0.000) regimens were found to be associated with non-adherence. Moreover, time since diagnosis was associated with adherence, as those tested HIV-positive >or= 6 months prior to date of interview (OR = 4.064, CI = 1.23-19.316, p = 0.047) had better adherence rate. CONCLUSION: The adherence rate obtained in this study was higher than the rates seen in developed countries despite the fact that many of the participants live in very poor conditions.
机译:目的:确定艾滋病毒/艾滋病患者艾滋病毒/艾滋病患者中艾滋病毒抗逆转录病毒治疗(HAART)的依从性率及其决定因素。方法论:涉及定性和定量方法的横断面研究是在2007年8月和10月在Yirgalem,Hawassa和Shashemene医院之间进行的。定量数据收集技术包括患者自我报告和未经报告的药丸数量,采用的定性方法是焦点组讨论(FGDS),半结构化访谈和卫生设施的观察。结果:虽然女性占56.4%(238年),男性参与者是总参与者的43.6%(184)名。使用15天的自我报告,依从性率为93.1%,但使用未通知的药丸数量(n = 90)计算速率降至88.1%。多变量分析显示,未婚(或= 0.119,CI = 0.016-0.901,P = 0.039),失业(或= 0.011,CI = 0.000-0.288,P = 0.007);未能公开HIV状态(或= 0.433,CI = 0.198-0.949,P = 0.037);家庭缺乏支持(或= 0.393,CI = 0.163-0.947,P = 0.037);或其他(或= 0.332,CI = 0.144-0.845,P = 0.043);酒精饮用(或= 0.210,CI = 0.071-0.617,P = 0.003);治疗方案,血管基(40) - 亚胺 - 奈韦拉滨(或= 0.174,CI = 0.033-0.923,P = 0.040),无己酰胺氨氨酸 - 拉布哌啶 - Nevirapine(或= 0.172,CI = 0.034-0.867,P = 0.033)和给药三个发现每日(或= 0.073,CI = 0.018-0.290,P = 0.000)方案与非粘附相关。此外,由于诊断与依从性有关,因为在访谈前测试的艾滋病毒阳性>或= 6个月(或= 4.064,CI = 1.23-19.316,P = 0.047)具有更好的依从性率。结论:本研究中获得的依从性率高于发达国家中看到的速率,尽管许多参与者生活在非常贫困的情况下。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号